Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongbi Tuomin nasal desensitization ointment is a topical traditional Chinese medicine (TCM) preparation developed by the Nanjing University of Chinese Medicine Affiliated Hospital (Jiangsu Provincial Hospital of Traditional Chinese Medicine). It is specifically formulated for the treatment of infantile allergic rhinitis. The ointment is applied intranasally and is intended to provide local desensitization of the nasal mucosa and alleviate allergic symptoms. Clinical research, including trial ChiCTR2200056952, has evaluated its efficacy and safety in pediatric populations, often comparing it to oral TCM decoctions or placebo (vaseline), while also investigating its impact on patient metabolomics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongbi Tuomin nasal desensitization ointment.